SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-001111
Filing Date
2021-02-03
Accepted
2021-02-03 08:00:22
Documents
3
Period of Report
2021-02-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT edsa_8k.htm 8-K 36737
2 STRATEGIC INNOVATION FUND AGREEMENT edsa_ex101.htm EX-10.1 352560
3 PRESS RELEASE edsa_ex991.htm EX-99.1 18543
  Complete submission text file 0001654954-21-001111.txt   409051
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 21584229
SIC: 2834 Pharmaceutical Preparations